Header image

HTLV-1 Session by ASHM Board and HTLV-1 National Advisory

Wednesday, August 31, 2022
2:00 PM - 3:30 PM
Minyama 3


Q&A Discussion

Q&A Discussion - HTLV-1 Session by ASHM Board and HTLV-1 National Advisory

Video / Recording


Agenda Item Image
Dr Fabiola Martin
Sexual Health Physician
University of Queensland, Sexual Health North Coast, NSW, Stonewall Medical Centre

International Advocacy and Strategic Directions (WHO/WHA, IRVA Global Call to Action)

2:00 PM - 2:20 PM

Video / Recording


I am a sexual & reproductive health HIV and HTLV physician working at Stonewall Medical Centre and Lilian Cooper Medical Centre in Brisbane. I also collaborate with GP practices in Springhill and at Sunshine Coast. I work as a Clinical Lead Educator at True Relationships and Reproductive Health as well as senior clinical fellow at School of Public Health at UQ.
Professor Damian Purcell
Professor of Virology
Doherty Institute, University Of Melbourne

Vaccination and drug pipelines – research update

2:20 PM - 2:40 PM

Video / Recording


Damian Purcell is University of Melbourne Professor of Virology and theme leader for viral infectious diseases at the Peter Doherty Institute. After a PhD studying primate retroviruses, his research on human HIV and HTLV-1 began in 1989 at the start of his NHMRC funded postdoc at the NIAID, NIH.  He is IRVA Regional Governing-Councillor, Past-President of the Australasian Virology Society, and ACH4 Executive Officer.
Agenda Item Image
Lloyd Einsiedel

Addressing the needs of communities affected by HTLV – treatment, care and support – barriers, challenges and opportunities

2:40 PM - 3:00 PM

Video / Recording


Lloyd Einsiedel (BM, BS (Hon), PhD, FRACP) is a clinical researcher and specialist in internal medicine and infectious diseases. His clinical experience in a region with the highest adult prevalence of HTLV-1 worldwide led to a particular interest in the epidemiology and clinical manifestations of HTLV-1. In collaboration with local and international researchers he continues to work to improve our understanding of the pathophysiology of HTLV-1 associated diseases and to provide actionable research to vulnerable Aboriginal communities in a region that has no public health response to HTLV-1.


Agenda Item Image
Skye McGregor
Epidemiologist, Lead Surveillance Innovation Group
Kirby Institute

Agenda Item Image
Ben Riley
Policy and Public Affairs Manager
ASHM Health